Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H31N3O2 |
| Molecular Weight | 393.5218 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC(=O)N1C=C2C[C@H]3N(C)C[C@@H](C=C3C4=CC=CC1=C24)C(=O)N(CC)CC
InChI
InChIKey=SVRFNPSJPIDUBC-DYESRHJHSA-N
InChI=1S/C24H31N3O2/c1-5-9-22(28)27-15-16-13-21-19(18-10-8-11-20(27)23(16)18)12-17(14-25(21)4)24(29)26(6-2)7-3/h8,10-12,15,17,21H,5-7,9,13-14H2,1-4H3/t17-,21-/m1/s1
| Molecular Formula | C24H31N3O2 |
| Molecular Weight | 393.5218 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 12:08:53 GMT 2025
by
admin
on
Wed Apr 02 12:08:53 GMT 2025
|
| Record UNII |
Y6JQX3L6LP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-1B-LSD
Created by
admin on Wed Apr 02 12:08:53 GMT 2025 , Edited by admin on Wed Apr 02 12:08:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
145875086
Created by
admin on Wed Apr 02 12:08:53 GMT 2025 , Edited by admin on Wed Apr 02 12:08:53 GMT 2025
|
PRIMARY | |||
|
1B-LSD
Created by
admin on Wed Apr 02 12:08:53 GMT 2025 , Edited by admin on Wed Apr 02 12:08:53 GMT 2025
|
PRIMARY | |||
|
2349376-12-9
Created by
admin on Wed Apr 02 12:08:53 GMT 2025 , Edited by admin on Wed Apr 02 12:08:53 GMT 2025
|
PRIMARY | |||
|
Y6JQX3L6LP
Created by
admin on Wed Apr 02 12:08:53 GMT 2025 , Edited by admin on Wed Apr 02 12:08:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET->PARTIAL AGONIST |
Ki
|
||
|
|
TARGET->PARTIAL AGONIST |
Ki
|
||
|
TARGET->PARTIAL AGONIST |
Ki
|
||
|
|
TARGET->PARTIAL AGONIST |
Emax=23%
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|